This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: United Immunity, Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Naozumi Harada: Inventor in Lipid Particle and Drug-Delivery Research
Introduction
Naozumi Harada is an inventor based in Tokyo, Japan, whose patent work focuses on pharmaceutical complexes and lipid particles. He is associated with United Immunity, Co., Ltd., and has 2 patents listed in the information provided.
Latest Patents
Harada’s latest patent work includes inventions addressing drug delivery and the properties of pharmaceutical compounds.
The patent titled “Lipid particle” describes a particle comprising an ionized lipid, a phospholipid, a sterol, and a hydrophobically modified polysaccharide. The invention aims to provide an alternative to lipid particles made with PEG-modified lipids, with potential benefits involving drug effects, safety, stability, or immunokinetics.
The patent titled “Complex” concerns a complex formed from a hydrophobically modified polysaccharide and a compound represented by formula (1). Its stated objectives include improving the compound’s poor water solubility and suppressing excessive cytokine release and bone marrow toxicity.
Career Highlights
Harada’s listed inventions address formulation challenges in pharmaceutical research, including solubility, drug-delivery characteristics, and potential safety considerations. His work is associated with United Immunity, Co., Ltd.
Collaborations
The provided information identifies Tadashi Inoue and Takatoshi Soga as Harada’s coworkers. Their names are associated with his professional context, though specific roles in the listed patents were not provided.
Conclusion
Naozumi Harada’s patent portfolio reflects work on lipid-based particles and pharmaceutical complexes, with an emphasis on drug-delivery properties, solubility, and safety-related objectives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile